Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: October 26, 2006
Last updated: October 31, 2014
Last verified: October 2014